1. Home
  2. CASS vs CSTL Comparison

CASS vs CSTL Comparison

Compare CASS & CSTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cass Information Systems Inc

CASS

Cass Information Systems Inc

N/A

Current Price

$52.41

Market Cap

714.9M

ML Signal

N/A

Logo Castle Biosciences Inc.

CSTL

Castle Biosciences Inc.

N/A

Current Price

$32.86

Market Cap

722.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CASS
CSTL
Founded
1906
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Business Services
Medical Specialities
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
714.9M
722.8M
IPO Year
1996
2019

Fundamental Metrics

Financial Performance
Metric
CASS
CSTL
Price
$52.41
$32.86
Analyst Decision
Hold
Strong Buy
Analyst Count
2
9
Target Price
★ $61.00
$48.20
AVG Volume (30 Days)
54.7K
★ 379.1K
Earning Date
10-22-2026
11-05-2026
Dividend Yield
★ 2.56%
N/A
EPS Growth
★ 87.77
N/A
EPS
★ 2.29
N/A
Revenue
$190,750,000.00
★ $344,229,000.00
Revenue This Year
N/A
$13.96
Revenue Next Year
$9.07
$10.65
P/E Ratio
$23.15
★ N/A
Revenue Growth
N/A
★ 3.66
52 Week Low
$39.85
$17.72
52 Week High
$59.63
$44.28

Technical Indicators

Market Signals
Indicator
CASS
CSTL
Relative Strength Index (RSI) 38.13 44.07
Support Level $51.96 $31.64
Resistance Level $52.82 $34.23
Average True Range (ATR) 1.22 1.76
MACD -0.23 -0.22
Stochastic Oscillator 6.58 19.48

Price Performance

Historical Comparison
CASS
CSTL

About CASS Cass Information Systems Inc

Cass Information Systems Inc is a provider of payment and information processing services to large manufacturing, distribution, and retail enterprises across the United States. The company provides transportation invoice rating, payment processing, auditing, accounting, and transportation information. It is also a processor and payer of energy invoices, including electricity, gas, waste, and other facility-related expenses. Additionally, the firm has a banking subsidiary, offering banking services mainly to privately held businesses in the St. Louis metropolitan area and restaurant franchises and faith-based ministries within the United States. The company operates in two reportable segments: Information Services, which generates the maximum revenue, and Banking Services.

About CSTL Castle Biosciences Inc.

Castle Biosciences Inc is a molecular diagnostics company. The group provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), and uveal melanoma. The product portfolio of the company includes DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test; DecisionDx-SCC, a risk stratification test for cutaneous squamous cell carcinoma; MyPath Melanoma, a diagnostic GEP test for use in patients with difficult-to-diagnose melanocytic lesions; and TissueCypher, a test to predict future development of progression of high-grade dysplasia and/or esophageal cancer. The company derives revenues through the delivery of test reports for its molecular diagnostic tests.

Share on Social Networks: